Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial.

Translated title of the contribution: Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial.

K.G. Auw Yang, N.J.H. Raijmakers, E.R.A. van Arkel, J.J. Caron, P.C. Rijk, W.J. Willems, J.A.C. Zijl, A.J. Verbout, W.J.A. Dhert, D.B.F. Saris

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionAutologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial.
Original languageUndefined/Unknown
Pages (from-to)498-505
Number of pages8
JournalOsteoarthritis and Cartilage
Volume16
Issue number4
Publication statusPublished - 2008

Cite this